AIM vs IBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

AIM

43.4
AI Score
VS
AIM Wins

IBIO

41.2
AI Score

Investment Advisor Scores

AIM

43score
Recommendation
HOLD

IBIO

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AIM IBIO Winner
Revenue 48,000 100,000 IBIO
Net Income -6.81M -8.99M AIM
Net Margin -14189.6% -8993.0% IBIO
Operating Income -5.74M -15.40M AIM
ROE -88.0% -15.9% IBIO
ROA -53.5% -14.0% IBIO
Total Assets 12.73M 64.39M IBIO
Cash 9.90M 28.67M IBIO
Current Ratio 2.11 9.04 IBIO

Relative Price Performance (Last 90 Days)

AIM 1M: -23.1% · 3M: -37.5% IBIO 1M: -40.2% · 3M: -50.5%

Current Technical Phase

AIM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.7%), weak momentum, RSI 32

RSI (14): 32.2 · Price: $0.16

IBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.0%), weak momentum, RSI 25

RSI (14): 24.9 · Price: $0.72

Fundamentals Snapshot

Metric AIM IBIO
Market Cap — —
Forward P/E -0.4 -2.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -1.0%
Gross Margin -0.2% 1.0%
Operating Margin -135.1% -301.4%
EPS -2.98 -0.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AIM is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.